174 related articles for article (PubMed ID: 24330746)
1. Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma.
Niyazi M; Karin I; Söhn M; Nachbichler SB; Lang P; Belka C; Ganswindt U
Radiat Oncol; 2013 Dec; 8():287. PubMed ID: 24330746
[TBL] [Abstract][Full Text] [Related]
2. Radiation treatment parameters for re-irradiation of malignant glioma.
Niyazi M; Söhn M; Schwarz SB; Lang P; Belka C; Ganswindt U
Strahlenther Onkol; 2012 Apr; 188(4):328-33. PubMed ID: 22349710
[TBL] [Abstract][Full Text] [Related]
3. A role for biological optimization within the current treatment planning paradigm.
Das S
Med Phys; 2009 Oct; 36(10):4672-82. PubMed ID: 19928099
[TBL] [Abstract][Full Text] [Related]
4. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
5. Coplanar versus noncoplanar intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) treatment planning for fronto-temporal high-grade glioma.
Panet-Raymond V; Ansbacher W; Zavgorodni S; Bendorffe B; Nichol A; Truong PT; Beckham W; Vlachaki M
J Appl Clin Med Phys; 2012 Jul; 13(4):3826. PubMed ID: 22766954
[TBL] [Abstract][Full Text] [Related]
6. Application of dose-volume histogram prediction in biologically related models for nasopharyngeal carcinomas treatment planning.
Cao W; Zhuang Y; Chen L; Liu X
Radiat Oncol; 2020 Sep; 15(1):216. PubMed ID: 32933543
[TBL] [Abstract][Full Text] [Related]
7. Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
Krauze AV; Peters C; Cheng J; Ning H; Mackey M; Rowe L; Cooley-Zgela T; Smart DD; Camphausen K
Radiat Oncol; 2017 Nov; 12(1):191. PubMed ID: 29187219
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
Schwarz M; Lebesque JV; Mijnheer BJ; Damen EM
Radiother Oncol; 2004 Nov; 73(2):209-18. PubMed ID: 15542168
[TBL] [Abstract][Full Text] [Related]
9. Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator.
Stewart AJ; Hepel JT; O'Farrell DA; Devlin PM; Price LL; Dale RG; Wazer DE
Radiother Oncol; 2013 Aug; 108(2):232-5. PubMed ID: 23891101
[TBL] [Abstract][Full Text] [Related]
10. Single arc volumetric modulated arc therapy for complex brain gliomas: is there an advantage as compared to intensity modulated radiotherapy or by adding a partial arc?
Davidson MT; Masucci GL; Follwell M; Blake SJ; Xu W; Moseley DJ; Sanghera P; Wong CS; Perry J; Tsao M; Sahgal A
Technol Cancer Res Treat; 2012 Jun; 11(3):211-20. PubMed ID: 22376134
[TBL] [Abstract][Full Text] [Related]
11. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
VanderSpek L; Fisher B; Bauman G; Macdonald D
Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
[TBL] [Abstract][Full Text] [Related]
12. EUD-based biological optimization for carbon ion therapy.
Brüningk SC; Kamp F; Wilkens JJ
Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
[TBL] [Abstract][Full Text] [Related]
13. Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison.
MacDonald SM; Ahmad S; Kachris S; Vogds BJ; DeRouen M; Gittleman AE; DeWyngaert K; Vlachaki MT
J Appl Clin Med Phys; 2007 Apr; 8(2):47-60. PubMed ID: 17592465
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
Li XA; Wang JZ; Stewart RD; DiBiase SJ
Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
[TBL] [Abstract][Full Text] [Related]
17. Re-Irradiation of Hepatocellular Carcinoma: Clinical Applicability of Deformable Image Registration.
Lee DS; Woo JY; Kim JW; Seong J
Yonsei Med J; 2016 Jan; 57(1):41-9. PubMed ID: 26632381
[TBL] [Abstract][Full Text] [Related]
18. Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort.
Niyazi M; Flieger M; Ganswindt U; Combs SE; Belka C
Radiat Oncol; 2014 Jun; 9():128. PubMed ID: 24893775
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cerebral malignant gliomas.
Zheng R; Fan R; Wen H; Luo J; Yang Y
J BUON; 2015; 20(1):248-52. PubMed ID: 25778324
[TBL] [Abstract][Full Text] [Related]
20. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Willner J; Jost A; Baier K; Flentje M
Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
